Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5243
Gene Symbol: ABCB1
ABCB1
0.010 Biomarker disease BEFREE Comparison of docetaxel-induced granulocytopenia in the two patients suggested a bone marrow-protective effect of the MDR1-transduced cells. 17683514 2007
Entrez Id: 28
Gene Symbol: ABO
ABO
0.010 GeneticVariation disease BEFREE The role of genetic factors in the pathogenesis of agranulocytosis was investigated in agranulocytosis patients by phenotyping for N-acetyltransferase and glucose-6-phosphate polymorphism; by typing for gene products of the major histocompatability complex, ABO- and RH-blood groups, and haemoglobins; and by performing cytogenetic analysis of chromosome aberrations. 8845862 1996
Entrez Id: 217
Gene Symbol: ALDH2
ALDH2
0.010 GeneticVariation disease BEFREE The ALDH2*1/*2 genotype was associated with leukocytopenia (<4,000/μl; adjusted odds ratio [95% confidence interval] = 1.89 [1.27 to 2.80]), granulocytopenia (<2,000/μl; 1.86 [1.22 to 2.82]), monocytopenia (<250/μl; 2.22 [1.49 to 3.29]), and lymphocytopenia (<1,000/μl; 1.93 [1.32 to 2.83]). 26917006 2016
Entrez Id: 8066
Gene Symbol: ANC
ANC
0.010 Biomarker disease BEFREE Agranulocytosis (absolute neutrophil count [ANC] nadir < 100 cells/mm<sup>3</sup>) developed in 49% of cases (n = 18), and there was an ANC nadir of 0 in 27% (n = 10). 31123688 2019
Entrez Id: 25842
Gene Symbol: ASF1A
ASF1A
0.010 GeneticVariation disease BEFREE Apart from identifying the CIA causal genes we identified several novel candidate genes which could be responsible for agranulocytosis. 21483481 2011
Entrez Id: 374569
Gene Symbol: ASPG
ASPG
0.010 GeneticVariation disease BEFREE A longer duration of coagulation dysfunction (9.80±5.51 vs. 6.80±4.21 days; P=0.002) and agranulocytosis (18.89±8.79 vs. 12.03±8.34 days; P<0.01), and a higher incidence of grade IV-V infections (22.73 vs. 7.25%; P=0.018) were observed in the PEG asparaginase group. 29387211 2018
Entrez Id: 465
Gene Symbol: ATD
ATD
0.010 GeneticVariation disease BEFREE Considering all data from 1660 patients treated with ATD for a mean duration of 5.8 years (around 10,000 patient-years), major complications occurred only in 14 patients: 7 severe agranulocytosis, 5 severe liver damage, one ANCA-associated glomerulonephritis and one vasculitis with small cutaneous ulcerations. 31134536 2019
Entrez Id: 1267
Gene Symbol: CNP
CNP
0.010 Biomarker disease BEFREE CNP exerts myeloprotective effects in cisplatin-induced granulocytopenia and decreases CXCR4 expression. 28101584 2017
Entrez Id: 1401
Gene Symbol: CRP
CRP
0.010 Biomarker disease BEFREE A previously healthy 11-month-old girl referred to our hospital because of fever, leukopenia, and elevated C-reactive protein presented to us with disturbance of consciousness, tachycardia, tachypnea and agranulocytosis. 28729050 2017
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.310 Biomarker disease CTD_human Full-dose CHOP chemotherapy combined with granulocyte colony-stimulating factor for aggressive non-Hodgkin's lymphoma in elderly patients: a prospective study. 11732872 2001
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.310 Biomarker disease CTD_human With GM-CSF starting on day 1, dose-limiting granulocytopenia occurred during cycle no. 8120554 1994
Entrez Id: 1437
Gene Symbol: CSF2
CSF2
0.310 Biomarker disease BEFREE These data suggest that GM-CSF may be a therapeutic option in some patients with LGLP complicated by granulocytopenia and/or infection. 1511064 1992
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Therapeutic disease CTD_human [Dapsone-induced agranulocytosis. The role of xenobiotic-metabolizing enzymes demonstrated by a case report]. 15999287 2005
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Biomarker disease BEFREE Agranulocytosis was treated with 8 doses of G-CSF with full recovery. 29181135 2017
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Biomarker disease BEFREE One had an autoimmune lymphoproliferative syndrome causing chronic agranulocytosis requiring granulocyte colony-stimulating factor injection. 29107664 2018
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 AlteredExpression disease BEFREE G-CSF-induced decrease of the anti-granulocyte autoantibody levels in a patient with autoimmune granulocytopenia. 9322685 1997
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Biomarker disease BEFREE Human granulocyte colony-stimulating factor produced by Escherichia coli shortens the period of granulocytopenia induced by irradiation in mice. 3115920 1987
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Biomarker disease BEFREE This meta-analysis aimed to assess the clinical effects of G-CSF and non-G-CSF on recovery duration in patients with ATD-induced agranulocytosis by analyzing the overall clinical outcomes. 31824417 2019
Entrez Id: 1440
Gene Symbol: CSF3
CSF3
0.360 Biomarker disease BEFREE Granulocytopenia was associated with impaired host defense and increased susceptibility to Escherichia coli K1 and Klebsiella pneumoniae sepsis in antibiotic-treated neonates, which could be partially reversed by administration of G-CSF. 24747744 2014
Entrez Id: 1536
Gene Symbol: CYBB
CYBB
0.010 Biomarker disease BEFREE Sequencing the entire coding region of the NADPH subunit CYBB (gpS1phase) disclosed that CYBB is a highly conserved gene, which does not represent a risk factor for clozapine-induced agranulocytosis. 15538122 2004
Entrez Id: 1564
Gene Symbol: CYP2D7
CYP2D7
0.010 GeneticVariation disease BEFREE Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6. 11147929 2000
Entrez Id: 1666
Gene Symbol: DECR1
DECR1
0.010 GeneticVariation disease BEFREE Sequencing the entire coding region of the NADPH subunit CYBB (gpS1phase) disclosed that CYBB is a highly conserved gene, which does not represent a risk factor for clozapine-induced agranulocytosis. 15538122 2004
Entrez Id: 2215
Gene Symbol: FCGR3B
FCGR3B
0.010 GeneticVariation disease BEFREE Hence, the analysis of FcγRIIIb polymorphism should be investigated in other cases of antipsychotic-induced agranulocytosis. 21965280 2012
Entrez Id: 2328
Gene Symbol: FMO3
FMO3
0.010 GeneticVariation disease BEFREE Our findings indicate that genetic variations in the FMO3 gene are associated with the response to ATDs maintenance treatment in ATD-induced agranulocytosis patients of -Chinese Han population. 30814476 2019
Entrez Id: 4616
Gene Symbol: GADD45B
GADD45B
0.010 GeneticVariation disease BEFREE In addition, carriers of GADD45A rs581000C had a lower risk of anemia, while carriers of GADD45B rs2024144T had a significantly higher risk for leukocytopenia or agranulocytosis. 26993769 2016